Alzheon, Inc.
Author: Michael
Alzheon, Inc.
EyePoint Pharmaceuticals announced that its indep
Biotechnology firm Oligomerix, Inc.
Vincere lands MJFF grant to support mitochondria
Proposed NIH cuts may not stand, but renewed deb
When longevity science becomes personalize
Zymo Research has entered a strategic partnership
Annovis Bio announced that the U.S.
Annovis Bio has reported new biomarker findings f